Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 5,233-5,244 of 10,612

Drug study icon

WithdrawnNCT02792153

Estradiol and Fear Extinction in Eating disorders (AN)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Eating disorders

Drug study icon

CompletedNCT04192266

Estrogen and Fear in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: The University of Texas Health Science Center, Houston
Condition: PTSD

Drug study icon

CompletedNCT03689543

Estrogen Receptor Beta and Mood

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 45 Years to 65 Years

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Depression

Drug study icon

CompletedNCT00120250

Eszopiclone for Sleep Disturbance and Nightmares in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 64 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: PTSD

Behavioral study icon

CompletedNCT01605253

Eszopiclone for PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Rush University Medical Center
Condition: PTSD

Drug study icon

CompletedNCT04315792

Endoxifen for Bipolarity

This study is completed in the United States. It is testing endoxifen for Bipolarity.

In United States

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Jina Pharmaceuticals Inc.
Condition: Bipolarity

Drug study icon

CompletedNCT02285504

Evaluate SAGE-547 in Female people with Severe Postpartum Depression

This study is completed in the United States. It focuses on depression.

In United States

DepressionDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: Supernus Pharmaceuticals, Inc.
Condition: Depression

Drug study icon

CompletedNCT00499863

Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 13 Years to 17 Years

Countries: United States
Sponsor: Noven Therapeutics
Condition: ADHD

Drug study icon

CompletedNCT02009163

Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating disorders

This study is completed in the United States, in Canada, in Germany, .... It focuses on Eating disorders.

In United States

Eating disordersDrugFrom 18 Years to 55 Years

Countries: United States, Canada, Germany, ...
Sponsor: Shire
Condition: Eating disorders

Drug study icon

CompletedNCT04572685

Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection for schizophrenia

This study is completed in the United States. It is testing Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection for schizophrenia.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Luye Pharma Group Ltd.
Condition: Schizophrenia

Drug study icon

CompletedNCT00501293

Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 13 Years to 17 Years

Countries: United States
Sponsor: Noven Therapeutics
Condition: ADHD

Drug study icon

CompletedNCT00214981

Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 6 Years to 17 Years

Countries: United States
Sponsor: Cephalon
Condition: ADHD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.